54 Views | 30 Downloads
Matthew R. Gardner, Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, GA 30329, USA. Email: matthew.r.gardner@emory.edu
M.R.G. designed the study and performed experiments. D.E.M. and C.P.M. performed experiments. J.M.M.-N. provided critical samples for analysis. S.P.F. performed data analysis. G.G. provided critical reagents. R.C.D. designed and supervised the study. M.R.G. and R.C.D. wrote the manuscript with input and approval from all the coauthors.
We would like to the thank William Lauer for his technical expertise and coordinating of sample distribution; Eva Rakasz for rhesus macaque sample collection and distribution; and Meredith E. Davis-Gardner for her insights and comments on the manuscript. The graphical abstract was created using BioRender.com.
M.R.G. is a co-founder and consultant for Emmune, Inc. M.R.G. is an inventor on patents with potential royalties licensed to Emmune, Inc. G.G. is a co-founder of Voyager Therapeutics and Aspa Therapeutics and holds equity in both companies. G.G. is an inventor on patents with potential royalties licensed to Voyager Therapeutics, Aspa Therapeutics, and other biopharmaceutical companies. The remaining authors declare no competing interests.
This work was supported by the Emory University Molecules and Pathogens to Populations and Pandemics (MP3) Initiative and by NIH grants R00AI138860 (M.R.G.), R01AI098446 (R.C.D.), and U19AI149646 (R.C.D.).
© 2022 The Authors